~~<i id='C9FF8B3A10'><strike id='C9FF8B3A10'><tt id='C9FF8B3A10'><pre id='C9FF8B3A10'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

hotspot

author：hotspot 2025-10-02 12:32:24 - browse：242

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Chemotherapy drug shortage eases slightly but still widespread

hotspot

Wikipedia

focus

leisure time

focus

MarkJ.Terrill/APAmidthestunningrebukeAmgensufferedatthehandsoftheU.S.FoodandDrugAdministrationthiswe

WSS

Physician executives need more than on

Liquid biopsy for lung cancer is launched by Delfi

3 questions for the future of Biden's cancer moonshot

Female surgeons have lower rates of long

Why age limits for politicians are a terrible idea

Readout LOUD podcast: Merger Mondays, Ozempic panic

leisure time

hotspot

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

The cancer drug shortage isn’t new — and neither are the solutions

When women are denied an abortion, their children fare worse than peers

At least 13 dead in Texas as scorching temps continue

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Cancer drug shortages should be causing more outrage

The future of health care in the House

Medical records are filled with copy

What to expect at HLTH 2023, the health care industry conference

hotspot

Nick Jonas talks about managing diabetes along with his career

Why age limits for politicians are a terrible idea

How should state employee insurance handle Wegovy?

How doctors and nurses shape Google's AI

European regulators recommend Amylyx's ALS drug be rejected

Senate panel eyes new effort on drug shortages

Wikipedia

focus

leisure time

focus